EIP
MRK icon

Ellis Investment Partners’s Merck MRK Stock Holding History

Ellis Investment Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.02M Sell
25,102
-2,670
-10% -$308K 0.52% 39
2025
Q4 		$2.92M Sell
27,772
-1,399
-5% -$131K 0.51% 44
2025
Q3 		$2.45M Buy
29,171
+740
+3% +$61K 0.44% 50
2025
Q2 		$2.25M Buy
28,431
+173
+0.6% +$13.8K 0.44% 52
2025
Q1 		$2.54M Buy
28,258
+1,959
+7% +$183K 0.52% 43
2024
Q4 		$2.62M Buy
26,299
+792
+3% +$81.7K 0.52% 45
2024
Q3 		$2.9M Buy
25,507
+1,584
+7% +$188K 0.56% 44
2024
Q2 		$2.96M Sell
23,923
-140
-0.6% -$18K 0.63% 36
2024
Q1 		$3.18M Buy
24,063
+46
+0.2% +$5.67K 0.69% 34
2023
Q4 		$2.62M Sell
24,017
-13
-0.1% -$1.35K 0.61% 41
2023
Q3 		$2.47M Sell
24,030
-80
-0.3% -$8.62K 0.64% 41
2023
Q2 		$2.78M Buy
24,110
+598
+3% +$67.9K 0.68% 36
2023
Q1 		$2.5M Sell
23,512
-316
-1% -$34.1K 0.65% 39
2022
Q4 		$2.64M Sell
23,828
-319
-1% -$32.6K 0.72% 37
2022
Q3 		$2.08M Buy
24,147
+73
+0.3% +$6.52K 0.58% 43
2022
Q2 		$2.19M Sell
24,074
-308
-1% -$27.3K 0.59% 41
2022
Q1 		$2M Sell
24,382
-750
-3% -$59.1K 0.47% 47
2021
Q4 		$1.93M Buy
25,132
+1,374
+6% +$109K 0.44% 50
2021
Q3 		$1.78M Buy
23,758
+697
+3% +$53K 0.45% 48
2021
Q2 		$1.79M Sell
23,061
-971
-4% -$72.2K 0.46% 48
2021
Q1 		$1.77M Sell
24,032
-358
-1% -$26.4K 0.49% 44
2020
Q4 		$1.9M Buy
24,390
+975
+4% +$74.6K 0.58% 41
2020
Q3 		$1.85M Buy
23,415
+1,340
+6% +$105K 0.65% 34
2020
Q2 		$1.65M Buy
22,075
+462
+2% +$34.8K 0.62% 38
2020
Q1 		$1.52M Buy
21,613
+385
+2% +$30.3K 0.72% 30
2019
Q4 		$1.86M Buy
21,228
+122
+0.6% +$10K 0.62% 34
2019
Q3 		$1.68M Buy
21,106
+582
+3% +$46.6K 0.61% 34
2019
Q2 		$1.66M Buy
20,524
+412
+2% +$31.5K 0.62% 34
2019
Q1 		$1.6M Sell
20,112
-875
-4% -$65.4K 0.65% 37
2018
Q4 		$1.52M Buy
+20,987
New +$1.48M 0.7% 35

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ellis Investment Partners's MRK Position: Q1 2026 in Review

Ellis Investment Partners reduced its Merck (MRK) stake by 9.6% in Q1 2026, selling an estimated $308K and leaving 25,102 shares worth $3.02M. The position accounts for 0.52% of the portfolio, ranked #39.

Ellis Investment Partners first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.18M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Ellis Investment Partners held 25,102 shares of Merck worth $3.02M as of Q1 2026.
  • Ellis Investment Partners sold 2,670 Merck shares in Q1 2026, an estimated $308K.
  • Merck made up 0.52% of Ellis Investment Partners's portfolio in Q1 2026, its #39 holding.
  • Ellis Investment Partners first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
  • Ellis Investment Partners's Merck position peaked at $3.18M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ellis Investment Partners's 13F filing for Q1 2026, filed 12 May 2026.